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Background: Chikungunya (CHIKV) is an arthropod-borne
virus belonging to the Alphavirus genus in the Togaviridae
family. Epidemic Chikungunya virus (CIKV) infections result
common limited to several countries of the tropical areas.
The only epidemic of CHIKV that aroused outside the trop-
ical areas was the small epidemic outbreak occurred in the
Emilia Romagna region, Italy, during summer of 2007. Local
transmission has been made possible by the enormous pop-
ulation of Aedes albopictus. On the basis of these facts,
a serological screening of chikungunya fever was initiated
by Centro Riferimento Regionale Emergenze Microbiologiche
(CRREM) of Bologna to determine the speciﬁc CHIKV IgG and
IgM titres in conﬁrmed CHIKV case.
Methods: Serum obtained from the 172 CHIKV infected
persons were collected and tested for the presence of CHIKV
antibodies. Speciﬁc antibodies titres were analyzed by an
indirect immunoﬂuorescence assay for the detection of anti-
CHIKV IgG and IgM by using a commercial EUROIMMUN assay.
Results: During the outbreak occurred in Emilia-Romagna
on 2007, all serum from laboratory conﬁrmed CHIKV infec-
tions were collected and tested as follows. Of these samples,
108 (62,8%) were CHIKV positive both in IgM and IgG, 27
(15,6%) were only IgM positive, 12 (6.9%) were IgG positive
only. In opposite, 25 (14,5%) were negative both for IgM and
IgG, but tested PCR positive. Moreover the 71,4% of the IgM
positive samples had a titre comprised between 1/100 and
1/1600. In addition the 85,8% of the IgG positive samples
had a titre ranging from 1/100 to 1/6400.
Conclusion: Here we report the ﬁrst sero-prevalence
study for speciﬁc CHIKV-antibodies in a population outside
the tropical geographic areas. In addition, this study was
performed on all the autochthonous CHIKV infected persons.
The results obtained clearly demonstrated the high level of
antibody response to CHIKV in the acute phase, or immedi-
ately after, infection. Studies are presently on going in order
to deﬁne the persistence of CHIKV speciﬁc antibodies.
doi:10.1016/j.ijid.2010.02.1951
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Background: West Nile virus (WNV) is a member of the ﬂa-
ivirus family and is transmitted in natural cycles between
irds and mosquitoes, particularly Culex spp. Human and
orses are susceptible but dead-end hosts. Firstly identi-
ed in tropical Africa, WNV infection has been evidenced in
orthern Africa, Israel, India and Australia. WNV spread in
merica since 1999 and has been the cause of outbreaks
nd sporadic cases in central eastern and Mediterranean
urope for more than 45 years. Of people infected with
osquito-borne WNV, 80% develop asymptomatic infections,
0% develop symptomatic infections and <1% develop severe
euro-invasive disease. The ﬁrst human cases of neuro-
nvasive WNV infection was identiﬁed in 2008 near Ferrara
rovince where had been identiﬁed several WNV-positive
orses and birds. After this ﬁrst case of WNV infection in
milia-Romagna, a sero-epidemiological survey was started
o ascertain the sero-prevalence of speciﬁc antibodies in the
lood donor population and the relative risk in population.
Methods: Serum obtained from 10.000 blood donors
esident in Ferrara province were collected between
eptember 2008 to April 2009, and tested for speciﬁc WNV.
irus-speciﬁc IgG were detected in serum specimens by
nzyme-linked immunosorbent assay (ELISA). To conﬁrm
esults of positive IgG samples and to determine the effec-
ively titers in the serum, an Immuno Fluorescent assay (IFA)
as performed.
Results: Between a period of 8 months, since autumn
008, 10.000 serum obtained by blood donors in Ferrara
rovince were collected and tested as described in previ-
usly. 70 of the 10.000 serum analyzed resulted positive in
gG. This data showing an incidence of 0.7% in a blood donors
opulation.
Conclusion: After the outbreak of WNV infections in Italy
uring the 2008, a sero-prevalence study was performed to
etermine the WNV mosquitoes-related infections in a blood
onors in Italy. We report the ﬁrst study of human sero-
revalence in Europe involving a high number of persons.
he ﬁrst data of the study show an incidence of 0,7% and
uggest the large diffusion of WNV in the area studied. In
ddition, the high incidence prospect a necessary surveil-
ance in blood and organ donors, performed by NAAT in this
art of Italy.
oi:10.1016/j.ijid.2010.02.1952
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Background: Lassa fever (LF) is associated with a wide
pectrum of clinical manifestations and its clinical diagnosis
s often complicated by the fact that the initial symptoms
f the disease are indistinguishable from a number of other
nfections seen in endemic areas. Over the years, many out-
reaks and deaths from LF have been reported in Nigeria
ostly associated with no or inadequate laboratory testing.
onsequently, the accuracy of clinical diagnosis is therefore
f interest.
Methods: Data including blood specimens and background
nformation were collected from 267 consented in- and
ut-patients clinically diagnosed to have LF at the Irrua
pecialist Teaching Hospital, Nigeria. Blood specimens were
ested for Lassa virus RNA using Reverse transcriptase poly-
erase chain reaction (RT-PCR). Data derived were analyzed
sing EpiInfo 6.04a version.
Results: Comparison of clinical diagnoses with laboratory
est results showed a low speciﬁcity of clinical judgement.
f the 267 clinically diagnosed cases, LF was laboratorycon-
rmed in 62 (23.2%), of which 35 (56%) were rightly treated
ith Ribavirin. On the other hand, 57 (28%) of the 205 LF
egative patients were erroneously treated with Ribavirin.
owever 35 (56%) of these patients recovered, 18 (29%) died
nd 1(2%) was referred to another hospital for further atten-
ion. Patients that tested positive to LF were more likely
o report vomiting, bleeding and have fever, sore throat,
eadache, abdominal pain and malaise than those that did
ot (p < 0.05).
Conclusion: Until now, the diagnosis of LF is mainly clini-
al, and was considered sufﬁcient for treatment decision.
nfortunately, clinical diagnosis of LF by health workers
s hardly achievable especially in the absence of haemor-
hage. Ribavirin can only help if it is administered early in
he course of illness. In the above elucidated challenge,
rompt diagnosis is clearly needed for early commence-
ent of treatment. The place of appropriate laboratory
upport in the effective and prompt diagnosis cannot be
ver-emphasized in the management of LF in all endemic
ountries of West Africa.
oi:10.1016/j.ijid.2010.02.1953
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Background: Syphilis remains an important public
ealth problem worlwide, despite preventive measure and
ffective treatment available for decades. The evolving epi-
o
A
a
aternational Congress on Infectious Diseases (ICID) Abstracts
emiology, changing risk groups, and social environments
resent challenges for syphilis control and further elimina-
ion. Population based syphilis prevalence studies are scarce
mong adolescent and youth, considered a vulnerable group
or sexually transmitted diseases (STD). To estimate the
revalence of syphilis in adolescents and young females,
exually active in central part of Brazil.
Methods: The study was a population-based cross sec-
ional study conducted among 15 to 24 years old sexually
ctive females attending Family Health Program (∼ 14.000
amilies registered at FHP), in three medium sized cities
∼10.650 to 75.600 inhabitants) of Goias State- Central
razil, from 2007 to 2009. Potential participants were ran-
omly selected from a nominal list of youth registered at
ocal FHS. Community health agents invited the participants
or an interview at the local health center. The demographic
ata and sexual behavior proﬁle were investigated by conﬁ-
ential interview. For those sexually active, a serum sample
as collected for syphilis diagnosis using two screening tests
VDRL and ELISA) followed by a conﬁrmatory test (FTA Abs).
Results: 1073 participants were interviewed, among
hem 698 (65.0%) were sexually active. The median age
f the ﬁrst sexual relation was 15.9 years (dp = 2.1), 73.5%
f the participants referred inconsistent condom use, and
8.8% had at least one previous pregnancy. Eleven women
ere positive on screening test (VDRL or ELISA) for syphilis.
ne sample was positive on screening and on the conﬁr-
atory test, yielding a syphilis prevalence of 0.14% (CI95%
.00-0.79).
Conclusion: The overall prevalence of syphilis was lower
han the expected for pregnant women and blood donors,
n Brazil. However, adolescents and young women, of the
valuated cities, reported high risk sexual behavior for SDT,
ointing out for the need of preventive strategies towards
yphilis control and future elimination. Financial support:
NESCO and Brazilian Health Ministry
oi:10.1016/j.ijid.2010.02.1954
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Background: Despite the increased mass of knowledge in
ifferent aspects of malaria, P. malariae is the least studied
f the four species that infect humans; in part because of
ts low prevalence. There is evidence that P. malariae infec-
ions are vastly underreported. We undertook a prospective
ohort study to investigate the clinical features of P. malar-
ae infections in endemic areas in Venezuela.
Methods: National malaria parasite data per year was
btained from the national malaria surveillance system.
prospective cohort study assessing the clinical and par-
sitological proﬁles of malaria infections was conducted
mong patients attending the malaria post at the Centro
